Capecitabine 500mg Tablet (Generic Xeloda® 500mg)

Capecitabine 500mg Tablet contains capecitabine, an oral fluoropyrimidine anticancer medicine used in approved treatment protocols for colorectal, breast and gastrointestinal cancers. Generic capecitabine 500mg is marketed as an alternative to Xeloda® 500mg, with manufacturer, excipients and packaging varying by product. Local terminology includes Capecitabin 500 mg Filmtabletten, capécitabine 500 mg, 카페시타빈 500mg and капецитабин 500 мг.

Product Information

• Generic Name: Capecitabine
• Strength: 500mg
• Dosage Form: Film-Coated Tablet
• Route: Oral
• Drug Class: Fluoropyrimidine Antimetabolite
• Reference Brand: Xeloda® 500mg
• Therapeutic Area: Oncology
• Prescription Status: Prescription medicine
• Manufacturer: Varies by generic product
• Pack Size: Varies by market and manufacturer

Main Uses

Capecitabine 500mg is used in approved treatment regimens for colorectal cancer, breast cancer, colon cancer and certain gastric or gastrointestinal cancers, depending on the local product authorization. It may be prescribed alone or with other anticancer medicines.

Generic Xeloda® 500mg

Xeloda® is the reference brand containing capecitabine. Generic capecitabine products contain the same active ingredient but may differ in manufacturer, inactive ingredients, tablet appearance and packaging.

France’s medicines database explicitly identifies Capecitabine 500mg products as generics in the Xeloda 500mg reference group, including Accord, Arrow, Biogaran, EG, Sandoz, Teva, Viatris and Zentiva products.

Commercial Availability

High-intent searches include capecitabine 500mg price, capecitabine 500mg tablet price, Xeloda 500mg, generic Xeloda 500mg, capecitabine 500mg pharmacy, capecitabine 500mg cost and capecitabine 500mg buy online.

Market terminology also differs significantly: Capecitabin 500 mg and Filmtabletten in Germany, capécitabine 500 mg in France, Xelabine 500mg in Australia, 카페시타빈 500mg in South Korea and капецитабин 500 мг in Russia.

Safety

Capecitabine is a prescription anticancer medicine with potentially serious adverse reactions. Current U.S. labeling includes a warning for serious or fatal toxicity in patients with complete DPD deficiency. Important toxicities can include diarrhea, mucositis, hand-foot syndrome, myelosuppression and cardiotoxicity. Patients require oncology supervision and appropriate pre-treatment assessment.

Frequently Asked Questions

What is Capecitabine 500mg used for?
It is used in approved treatment regimens for colorectal, breast and certain gastrointestinal cancers.

Is Capecitabine 500mg the generic version of Xeloda 500mg?
Yes. Xeloda® is the reference brand containing capecitabine.

Is Capecitabine 500mg a tablet?
Yes. Current U.S. and UK product information documents 500mg film-coated tablets.

Is Capecitabine 500mg prescription-only?
Yes. It is supplied as a prescription oncology medicine, with specific dispensing requirements varying by country.

What is DPD testing for capecitabine?
DPD assessment is used to identify patients at increased risk of severe fluoropyrimidine toxicity. Current European product information recommends testing before treatment.

Last Updated: September 27, 2026 | Medically Reviewed By: Licensed Pharmacist

Medical Disclaimer:
This information is for educational and product-identification purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Capecitabine should be used only under appropriate oncology supervision.